Enhancement of recombinant human bone morphogenetic protein-2 (rhBMP-2)-induced new bone formation by concurrent treatment with parathyroid hormone and a phosphodiesterase inhibitor, pentoxifylline.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples